Comparative Pharmacology
Head-to-head clinical analysis: METHADOSE versus PHENAPHEN W CODEINE NO 3.
Peer-Reviewed Evidence
Head-to-head clinical analysis: METHADOSE versus PHENAPHEN W CODEINE NO 3.
METHADOSE vs PHENAPHEN W/ CODEINE NO. 3
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Methadone is a mu-opioid receptor agonist; it also acts as an NMDA receptor antagonist and inhibits serotonin and norepinephrine reuptake, contributing to its analgesic and detoxification effects. It has a long half-life and reduces opioid craving and withdrawal symptoms.
Codeine is an opioid agonist that binds to mu-opioid receptors, inhibiting adenylate cyclase and reducing cAMP production, leading to decreased neurotransmitter release and modulation of pain perception. Acetaminophen produces analgesia through central cyclooxygenase (COX) inhibition and activation of descending serotonergic pathways.
Oral: 20-40 mg once daily, titrated to effect; for opioid dependence, typical maintenance 80-120 mg/day. IV: 2.5-10 mg every 8-12 hours.
One to two tablets (30-60 mg codeine phosphate/300-600 mg acetaminophen) orally every 4 hours as needed for pain, maximum 12 tablets per day.
None Documented
None Documented
Terminal elimination half-life range: 8–59 hours (mean ~20–35 hours). In chronic use, half-life may increase due to accumulation. Context: The long half-life supports once-daily dosing for opioid dependence but requires careful titration to avoid accumulation.
Codeine: terminal elimination half-life is 2.5–3.5 hours in healthy adults; morphine: 1.5–4.5 hours; morphine-6-glucuronide: 2.5–4.5 hours. Half-life is prolonged in hepatic or renal impairment; in end-stage renal disease, half-life of codeine and metabolites may exceed 24 hours.
Primarily renal (approximately 80%) as inactive metabolites, with about 20% eliminated via feces. Less than 10% excreted unchanged.
Renal excretion of codeine and its metabolites (morphine, norcodeine, codeine-6-glucuronide, morphine-3-glucuronide, morphine-6-glucuronide). Approximately 80-90% of the dose is eliminated in urine within 24 hours, with about 10% as unchanged codeine, 10% as norcodeine, 10% as free and conjugated morphine, and the remainder as conjugated codeine and other metabolites. Fecal excretion accounts for less than 10%.
Category C
Category D/X
Opioid Agonist
Opioid Agonist